healthcare
UK Preparing to Meet 'inevitable' Increased Drug Costs After US Talks
Novartis Could Expand Direct-To-Patient Sales in Us, CEO Says
Dna From Mass Grave Reveals Pathogens That Beset Napoleon's Army in 1812
US Fda Approves Bayer's Menopause Relief Drug
Novo Nordisk's New Chairman Has 'carte Blanche' After Board Clear-Out
Date: October 24, 2025
By Maggie Fick and Jacob Gronholt-Pedersen LONDON/COPENHAGEN (Reuters) -A boardroom shake-up at Novo Nordisk has handed unprecedented power to its top shareholder, the Novo Nordisk Foundation,...
UK Industry Body Finds AstraZeneca in Breach of Code Over Symbicort Marketing
Date: October 24, 2025
(Reuters) -AstraZeneca has breached the UK pharmaceutical industry's code of practice, an industry self-regulatory body ruled on Friday, after incorrect claims related to the drugmaker's asthma...
UK Seizes Record Haul of Illegal Weight-Loss Drugs in Factory Raid
Date: October 24, 2025
LONDON (Reuters) -Britain's medicines regulator on Friday said it had made the largest single seizure of trafficked weight loss medicines recorded globally, dismantling a factory making thousands of...
Dutch Election: What You Need to Know
Date: October 23, 2025
By Canan Sevgili, Arda Dipova and Jakob Van Calster (Reuters) -The Netherlands will hold a general election on October 29 after the previous government collapsed. Geert Wilders' far-right PVV leads...
Women-Focused Weight-Loss Startup SheMed Raises $50 Million at $1 Billion Valuation
Date: October 23, 2025
(Reuters) -London-based startup SheMed, which offers personalized weight-loss plans using popular medicines Wegovy and Mounjaro, said on Thursday it has raised $50 million in its Series A funding...
Analysis-Novo's Board Bust-Up to Sharpen Drugmaker's Focus on US Consumers
Date: October 22, 2025
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Boardroom drama at Wegovy-maker Novo Nordisk has laid bare the company's biggest challenge: how to better tap into America's mass market for weight-...